Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoYToronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia...
Announces it has entered into a non-binding amended and restated Letter of Intent for a business combination ...
Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and developmentEstablishes large footprint of 17 specialized mental health...
Completed the acquisition of two ketamine clinics in Georgia through an asset purchase of Invictus Clinics, ...
The national chain of psychedelic mental-healthcare clinics growing rapidly...
Company announces licensing agreement with Entourage Brands for Canadian distribution of cannabis products...
Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent...
Company’s national rollup accelerating with acquisition of New Hampshire ketamine clinic...
Company continues national growth trajectory for Emergence clinics focusing on total wellness including the therapeutic use of ketamine...
Cannabis Licensing and Ketamine ClinicRollup Strategy Accelerating Growth Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST LOS...